China patent. First of all I want to again expres
Post# of 9144
Posted On: 06/20/2015 12:31:35 PM
China patent. First of all I want to again express my appreciation for the heroic efforts of Microcaps aimed at dealing with the incessant "Chinese Water Torture" drips provided by the bashers he described so accurately in a recent post. His description nailed the exact strategies employed by several "contributors", some of whom clearly are simply new names for old garbage providers. I appreciate his efforts more than I can express.
But in relation to the recent NanoLogix revelation about the grant of a patent in China it is difficult to overemphasize the economic potential including licensing and joint ventures. China is everything that Africa is not in relation to the adoption, need and use of the long life packaging technology. Why is that? Africa is greatly in need of the technology but lacks trained medical personnel, adequate medical on-location treatment and evaluation centers outside cities other than limited WHO and NGO points. Much of Africa is also in a set of regional, tribal and local strife that makes distribution of anything extremely uncertain. What could and should be a positive market for NNLX tech based on need is a situation of crazy-quilt and often dangerous disconnected pieces that do not communicate with each other or are actually in conflict.
Now transfer from that situation of what should happen in Africa (but won't) to that of China. China is vast and has extremely diverse conditions in the countryside. But unlike most of the African nations, China has millions of educated people, a political organization, national and regional coordination, transportation and delivery systems, medical centers in cities and in rural areas, trained personnel and financial resources. In the non-urban rural areas particularly, where 800,000,000 Chinese live, there is an immense market for long-lasting test kits that can last for up to two years (at least) in moderate climatic conditions and still render accurate readings when needed.
The financial and health implications of this patent are immense and the fact that NanoLogix has a distributor in Singapore is very important since the Chinese tend to be quite insular and Singapore is mainly populated by ethnic Chinese business-oriented people with connections in mainland China and the ability to understand and ride herd on the tendency of the Chinese to play a bit fast-and-loose with foreign investors and technology. All in all this is an exciting development. Congratulations to NanoLogix and its management.
But in relation to the recent NanoLogix revelation about the grant of a patent in China it is difficult to overemphasize the economic potential including licensing and joint ventures. China is everything that Africa is not in relation to the adoption, need and use of the long life packaging technology. Why is that? Africa is greatly in need of the technology but lacks trained medical personnel, adequate medical on-location treatment and evaluation centers outside cities other than limited WHO and NGO points. Much of Africa is also in a set of regional, tribal and local strife that makes distribution of anything extremely uncertain. What could and should be a positive market for NNLX tech based on need is a situation of crazy-quilt and often dangerous disconnected pieces that do not communicate with each other or are actually in conflict.
Now transfer from that situation of what should happen in Africa (but won't) to that of China. China is vast and has extremely diverse conditions in the countryside. But unlike most of the African nations, China has millions of educated people, a political organization, national and regional coordination, transportation and delivery systems, medical centers in cities and in rural areas, trained personnel and financial resources. In the non-urban rural areas particularly, where 800,000,000 Chinese live, there is an immense market for long-lasting test kits that can last for up to two years (at least) in moderate climatic conditions and still render accurate readings when needed.
The financial and health implications of this patent are immense and the fact that NanoLogix has a distributor in Singapore is very important since the Chinese tend to be quite insular and Singapore is mainly populated by ethnic Chinese business-oriented people with connections in mainland China and the ability to understand and ride herd on the tendency of the Chinese to play a bit fast-and-loose with foreign investors and technology. All in all this is an exciting development. Congratulations to NanoLogix and its management.
(0)
(0)